Detalhe da pesquisa
1.
Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity.
FEBS J
; 289(15): 4657-4673, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090199